Genzyme to acquire Diagnostic Chemicals unit for $56.5M

11/11/2007 | American City Business Journals

Genzyme Corp. has agreed to purchase the diagnostics division of Canadian biotech firm Diagnostic Chemicals Ltd. for $56.5 million. The deal, which is anticipated to conclude in December, permits Genzyme to acquire more than 50 clinical chemistry reagents and diagnostics operations in Canada and Connecticut.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care